Did Magnera beat or miss consensus estimates last quarter?

What is the market's earnings forecast for Magnera next quarter?

What guidance did Magnera's management provide for the next earnings period?

What is Magnera's gross profit margin?

What were the key takeaways from Magnera’s earnings call?

What is Magnera's latest dividend and current dividend yield?

What were the key takeaways from Magnera's earnings call?

What is the revenue and EPS growth rate for Magnera year over year?

- **Revenue Resilience**: Americas growth (2% organic) offset South America softness; Rest of World EBITDA up 9% on cost control.
- **Project CORE Momentum**: $15-20M annual savings target, with $25M synergy realization in 2026.
- **Innovation Payoff**: Advanced battery materials and PFAS-free healthcare solutions drive premium margins (mid-teens to 20%).
- **South America Shift**: Adult incontinence products now 20% of portfolio, targeting 50-50 split with baby products.
- **Cash Flow Strength**: $97M free cash flow, $100M debt repayment target to reduce leverage to 3x.

**【CEO Summary Section】**
- **Revenue Performance**: Sequential earnings improvement in line with expectations, with Rest of World segment showing earnings improvement due to cost structure optimization and consumer solution mix. Americas segment saw 2% organic volume growth in wipes and adult end markets, offsetting South America's competitive pressures.
- **Project CORE Progress**: Cost reduction initiatives and productivity gains expected to support margin recovery. South America stabilization anticipated as prior-year comparisons ease in Q3.
- **Innovation Highlights**: Launch of PFAS-free healthcare barrier protection and advanced battery materials solution. Kamisoft platform sales grew to $15M in 2025, with mid-single-digit growth in 2026. Adult incontinence products now 20% of South America portfolio, targeting 50-50 split with baby products.
- **Strategic Priorities**: Global cost structure optimization, product leadership through innovation, and commercial excellence to maximize portfolio value.

**【CFO Financial Commentary】**
- **Q1 2026 Results**: Sales $792M, adjusted EBITDA $93M (flat YoY). Americas EBITDA declined $3M due to South America volume/mix pressures; Rest of World EBITDA up 9% to $35M on cost management and synergy realization.
- **Cash Flow**: Free cash flow $97M (18% yield). Debt repayment of $27M in Q1, targeting $100M annual reduction to achieve 3x leverage ratio.
- **Segment Breakdown**: Americas growth in wipes and adult incontinence offset South America softness; Rest of World resilience in Europe despite market softness.

**【Q&A Highlights】**
- **South America Antidumping Measures**: Expected resolution in May; 20% adult incontinence portfolio mix in South America, targeting 50-50 split with baby products.
- **Operational Impact of Storms**: 10% shipping day disruption in North America, no customer supply issues; Q2 recovery expected.
- **Project CORE**: $15-20M annual benefit target, on track with slight delays in execution.
- **Innovation Margins**: Proprietary products expected to generate mid-teens to 20%+ margins, above 11% average.
- **2026 Outlook**: Flat volumes, EBITDA growth driven by synergies ($25M) and Project CORE; 2027+ growth to be evaluated later.

Magnera Corporation (MAGN) Q1 2026 Earnings Call Transcript

- **Record Cash Flow**: $126M free cash flow (30% yield) and 3.8x debt leverage highlight financial strength. 
- **9% EBITDA Growth Target**: 2026 outlook driven by $395M midpoint, 70%+ synergy realization. 
- **Consumer Solutions Growth**: Wipes +10%, adult incontinence mid-single digits, 53% consumer solutions mix. 
- **Risks**: Europe softness, South America lapping tough comps, cautious macro outlook. 
- **Strategic Focus**: Project CORE cost savings, ESG-aligned innovation, and disciplined capital allocation.

**【CEO Summary Section】**
- **Financial Highlights**: Q4 2025 revenue of $839 million, full-year revenue $3.2 billion, adjusted EBITDA $362 million, and free cash flow $126 million (30% yield). 
- **Market Share Gains**: Gained share in select consumer solutions (53% of revenue) and wipes (10% YoY growth). 
- **2026 Outlook**: 9% EBITDA growth driven by synergies, Project CORE, and product mix improvements. 
- **Challenges**: Softness in Europe and South America, cautious macro outlook. 
- **Strategic Focus**: Operational excellence, balance sheet strength, and ESG-aligned innovation (e.g., compostable materials). 

**【CFO Financial Commentary】**
- **Cash Generation**: Full-year free cash flow exceeded guidance at $126 million, debt leverage reduced to 3.8x. 
- **Segment Performance**: Rest of World EBITDA +$4M vs. Q3, Americas down 9% due to South America headwinds. 
- **2026 Guidance**: EBITDA $395M midpoint (+9%), free cash flow $90-110M, capex $80M (including $10M IT). 
- **Cost Control**: 70-75% of remaining synergies to be realized, Project CORE benefits ramping Q3+2026. 

**【Q&A Highlights】**
- **EBITDA Range Drivers**: Volume flattish (puts/takes by region), 50%+ margin expansion from synergies. 
- **Demand Trends**: North America resilient, Europe cautious, South America lapping tough comps. 
- **Cash Allocation**: Debt reduction priority, no share buyback plans. 
- **Integration Progress**: Procurement 75%+ savings, Project CORE on track for Q3+ impact. 
- **CapEx Strategy**: 2-3% of sales for maintenance/growth, no large line investments planned.

Magnera Corporation (MAGN) Q4 2025 Earnings Call Transcript

- **Revenue Growth**: Q3 2025 sales of $839 million, adjusted EBITDA $91 million, reflecting cost-saving initiatives.
- **Project CORE Savings**: $20 million annual savings from operational consolidation.
- **Regional Challenges**: South America volume decline due to import competition, stable North America demand.
- **Debt Reduction Target**: 3x net debt ratio by 2026.
- **Cash Flow Management**: $85 million free cash flow guidance, disciplined CapEx.
- **Strategic Focus**: High-margin product expansion, customer engagement, and supply chain resilience.


**【CEO Summary Section】**
- **Revenue Performance**: Q3 2025 sales of $839 million, with adjusted EBITDA of $91 million, reflecting strong execution of cost-saving initiatives and synergy capture.
- **Project CORE**: Announced $20 million annual cost savings starting FY2026, focusing on capacity optimization and operational efficiency across global manufacturing footprint.
- **Regional Highlights**: Americas division revenue $473 million, stable demand in North America consumer solutions, challenges in South America due to import competition.
- **Strategic Priorities**: Debt repayment target of 3x net debt ratio, free cash flow guidance of $85 million, disciplined capital expenditure management.

**【CFO Financial Commentary】**
- **Financial Health**: Net debt to EBITDA ratio 3.9x, $570 million liquidity, focus on balance sheet strength and operational agility.
- **Cost Optimization**: $55 million synergy target by 2027, with $20 million annual savings from Project CORE.
- **Cash Flow Management**: Free cash flow generation through working capital initiatives and CapEx discipline.

**【Q&A Highlights】**
- **Project CORE Details**: 5% global capacity optimization, 1:1 cost-to-benefit ratio, targeting 2026 savings.
- **Regional Volume Trends**: Q3 volume decline of 5%, stability in North America, challenges in Europe and South America.
- **Customer Relationships**: Long-term partnerships, product innovation driving growth in personal care and food protection solutions.
- **2026 Outlook**: Focus on cost reduction, free cash flow improvement, and selective investments in high-margin products.


Magnera Corporation (MAGN) Q3 2025 Earnings Call Transcript

- **Q2 Revenue Performance**: $824M with North America infrastructure growth offsetting European energy headwinds. New products (TYPAR, KamiSoft) drive differentiation.
- **Profit Margins Under Pressure**: $89M EBITDA (-8% YoY) due to Europe energy costs. Free cash flow ($42M) supports $75-95M guide amid cautious CapEx ($23M).
- **Market Uncertainty**: Flat Q3/Q4 volume outlook vs. prior year; cautious customer inventory management. Europe energy costs to recover in Q3.
- **Liquidity Strength**: $570M liquidity (14% QoQ increase) supports debt reduction to 3x leverage.
- **Key Risks**: Global supply chain rebalancing, raw material price volatility, and customer inventory correction.

**【CEO Summary Section】**
- Q2 revenue of $824M reflects strength in North America (infrastructure and wipes) offset by weakness in South America and Europe. Key growth drivers include new product launches like TYPAR Clear Acrylic Flashing and KamiSoft/UltraSoft incontinence products.
- Energy inflation in Europe (+50% YoY) and raw material cost increases were partially offset by price pass-through mechanisms. Synergy realization progress: $55M 3-year target remains intact, with 2026 acceleration expected.
- Market uncertainty led to cautious Q2 guidance ($360-380M EBITDA), with flat Q3/Q4 volume outlook vs. historical Q3/Q4 growth. Focus on free cash flow ($75-95M) and debt reduction to 3x leverage.

**【CFO Financial Commentary】**
- GAAP net income: $420M; Non-GAAP EPS: $1.08 (exceeds expectations). Adjusted EBITDA: $89M (-$8M YoY due to Europe energy costs and product mix).
- Americas division: Flat revenue ($473M) vs. prior year, driven by infrastructure growth offset by South America competition. Rest of World: $351M (-$5M EBITDA YoY due to Europe energy and soft demand).
- Free cash flow: $42M (vs. $23M prior year), with $570M liquidity. CapEx reduced to maintenance levels ($23M) amid soft demand.

**【Q&A Highlights】**
- **Tariff Impact**: Minimal direct effect on COGS; focus on price recovery and local supply chain flexibility. North America new product launches may offset global supply chain shifts.
- **Volume Outlook**: Flat Q3/Q4 vs. prior year, driven by cautious customer inventory management. No material change in utilization rates ($824M revenue reflects 90%+ capacity usage).
- **Synergy Execution**: Procurement and SG&A savings on track; 2026 acceleration expected. No CapEx delays for synergies; innovation spending maintained despite CapEx cuts.
- **Recession Risk**: Resilient portfolio (essential products) expected to outperform; infrastructure and wipes end markets less cyclical than consumer discretionary.

Actual											2.86	2.08	2.86	2.47	2.34	2.73	0.52	-1.82	-0.52	-1.3	-2.08	-1.69	-5.85	-2.99	-0.52					-1.69	-1.15	-0.51	-0.0573	0.2452
Forecast											2.145	2.08	2.08	2.34	1.82	2.6	1.43	-0.91	-2.99	-0.52	0.65	0.78	0.78	1.04	1.82					-0.1	0.1427	0.0297	-0.0837	0.2452
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+33.33%	0.00%	+37.50%	+5.56%	+28.57%	+5.00%	-63.64%	-100.00%	+82.61%	-150.00%	-420.00%	-316.67%	-850.00%	-387.50%	-128.57%	0.00%	0.00%	0.00%	0.00%	-1590.00%	-905.89%	-1817.17%	+31.54%	0.00%

Actual	--	--	--	--	--	--	--	--	--	--	216.18M	233.47M	235.28M	225.67M	244.91M	279.65M	334.46M	381.68M	363.96M	371.78M	373.90M	378.21M	357.00M	329.92M	320.38M	--	--	--	--	702.00M	824.00M	839.00M	839.00M	743.63M
Forecast	--	--	--	--	--	--	--	--	--	--	201.67M	225.16M	229.00M	224.00M	242.00M	270.00M	353.00M	332.75M	355.00M	401.00M	397.00M	400.90M	380.10M	390.90M	382.00M	--	--	--	--	845.00M	825.84M	850.13M	841.50M	743.63M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+7.19%	+3.69%	+2.74%	+0.75%	+1.20%	+3.57%	-5.25%	+14.70%	+2.52%	-7.29%	-5.82%	-5.66%	-6.08%	-15.60%	-16.13%	0.00%	0.00%	0.00%	0.00%	-16.92%	-0.22%	-1.31%	-0.30%	+0.00%

MAGN

MAGN fundamentals

MAGN Q1 2026 Earnings

Earnings Call

You can ask Aime

MAGN

MAGN fundamentals

MAGN Q1 2026 Earnings

Earnings Call

MAGN Earnings Call Summary for Q1/202610:00 AM on Feb 5, 2026

MAGN Earnings Call Summary for Q4/202510:00 AM on Nov 20, 2025

MAGN Earnings Call Summary for Q3/202510:00 AM on Aug 6, 2025

MAGN Earnings Call Summary for Q2/202510:00 AM on May 7, 2025

MAGN Earnings Call Summary for Q1/2025 Apr 1, 2026

You can ask Aime